rs368193507
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000814.6(GABRB3):c.156A>T(p.Leu52Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000241 in 1,576,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L52L) has been classified as Likely benign.
Frequency
Consequence
NM_000814.6 synonymous
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 43Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- epilepsy, childhood absence, susceptibility to, 5Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABRB3 | NM_000814.6 | c.156A>T | p.Leu52Leu | synonymous_variant | Exon 2 of 9 | ENST00000311550.10 | NP_000805.1 | |
| GABRB3 | NM_021912.5 | c.156A>T | p.Leu52Leu | synonymous_variant | Exon 2 of 9 | NP_068712.1 | ||
| GABRB3 | NM_001278631.2 | c.-196A>T | 5_prime_UTR_variant | Exon 2 of 10 | NP_001265560.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151440Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000315 AC: 7AN: 222360 AF XY: 0.0000329 show subpopulations
GnomAD4 exome AF: 0.0000246 AC: 35AN: 1424892Hom.: 0 Cov.: 32 AF XY: 0.0000254 AC XY: 18AN XY: 708738 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151440Hom.: 0 Cov.: 34 AF XY: 0.0000271 AC XY: 2AN XY: 73936 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Epilepsy, childhood absence, susceptibility to, 1;C2677087:Epilepsy, childhood absence, susceptibility to, 5 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at